þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 04-3324394 | |
(State or other jurisdiction of | (I.R.S. Employer | |
incorporation or organization) | Identification No.) | |
8 Sylvan Way | 07054 | |
Parsippany, New Jersey | (Zip Code) | |
(Address of principal executive offices) |
Large accelerated filer o | Accelerated filer þ | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
1 | ||||||||
2 | ||||||||
3 | ||||||||
EX-101 INSTANCE DOCUMENT | ||||||||
EX-101 SCHEMA DOCUMENT | ||||||||
EX-101 CALCULATION LINKBASE DOCUMENT | ||||||||
EX-101 LABELS LINKBASE DOCUMENT | ||||||||
EX-101 PRESENTATION LINKBASE DOCUMENT |
Item 6. | Exhibits |
1
THE MEDICINES COMPANY |
||||
Date: August 17, 2010 | By: | /s/ Glenn P. Sblendorio | ||
Glenn P. Sblendorio | ||||
Executive Vice President and Chief Financial
Officer (Principal Financial and Accounting Officer) |
2
Exhibit Number | Description | |
10.1*
|
Second Amendment to License Agreement dated as of June 1, 2010 between AstraZeneca AB and the registrant (filed as an exhibit to the registrants Quarterly Report on Form 10-Q for the quarter ended June 30, 2010) | |
10.2
|
The Medicines Companys 2010 Employee Stock Purchase Plan (incorporated by reference to Appendix I to the registrants definitive proxy statement, dated and filed with the Securities and Exchange Commission on April 30, 2010, for the registrants 2010 Annual Meeting of Stockholders). | |
10.3
|
The Medicines Companys 2004 Amended and Restated Stock Incentive Plan, as amended (incorporated by reference to Appendix II to the registrants definitive proxy statement, dated and filed with the Securities and Exchange Commission on April 30, 2010, for the registrants 2010 Annual Meeting of Stockholders). | |
31.1*
|
Chairman and Chief Executive Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed as an exhibit to the registrants Quarterly Report on Form 10-Q for the quarter ended June 30, 2010) | |
31.2*
|
Chief Financial Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed as an exhibit to the registrants Quarterly Report on Form 10-Q for the quarter ended June 30, 2010) | |
32.1*
|
Chairman and Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed as an exhibit to the registrants Quarterly Report on Form 10-Q for the quarter ended June 30, 2010) | |
32.2*
|
Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed as an exhibit to the registrants Quarterly Report on Form 10-Q for the quarter ended June 30, 2010) | |
101.INS**
|
XBRL Instance Document | |
101.SCH**
|
XBRL Taxonomy Extension Schema | |
101.CAL**
|
XBRL Taxonomy Extension Calculation Linkbase | |
101.DEF**
|
XBRL Taxonomy Extension Definition Linkbase | |
101.LAB**
|
XBRL Taxonomy Extension Label Linkbase | |
101.PRE**
|
XBRL Taxonomy Extension Presentation Linkbase |
| Confidential treatment requested as to certain portions, which portions have been omitted and filed separately with the Securities and Exchange Commission Unless otherwise indicated, the exhibits incorporated herein by reference were filed under Commission file number 000-31191. | |
* | Previously filed or furnished, as applicable, with the registrants Form 10-Q as filed on August 9, 2010 | |
** | Furnished with this Form 10-Q/A |
3